MyFinsight
Home
About
Contact
axsm: the income statement
Download
Download image
Net loss
-$47,229K
(26.89%↑ Y/Y)
Loss before income
taxes
-$47,229K
(26.89%↑ Y/Y)
Royalty
$1,208K
Product
$169,784K
Interest expense, net
-$1,120K
(43.38%↑ Y/Y)
Loss from operations
-$46,109K
(26.37%↑ Y/Y)
Revenue
$170,992K
(63.22%↑ Y/Y)
Total operating
expenses
$217,101K
(29.70%↑ Y/Y)
Intangible asset
amortization
$1,607K
(0.06%↑ Y/Y)
Loss in fair value of
contingent consideration
$13,185K
(-19.56%↓ Y/Y)
Selling, general and
administrative
$150,235K
(57.21%↑ Y/Y)
Research and development
$40,162K
(-11.51%↓ Y/Y)
Cost of revenue
(excluding amortization...
$11,912K
(41.19%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)